Novartis AG Deferred Tax Liabilities Recognised As Of Acquisition Date
Novartis AG (NVS) had Deferred Tax Liabilities Recognised As Of Acquisition Date of $799.00 million as of 2024-12-31, per its 20-F filed 2026-02-04.
Financial Statements › Notes › Income Taxes
ifrs-full:DeferredTaxLiabilitiesRecognisedAsOfAcquisitionDate · last filed 2026-02-04
- 2024-12-31: Deferred Tax Liabilities Recognised As Of Acquisition Date $799.00M.
- 2024-06-30: Deferred Tax Liabilities Recognised As Of Acquisition Date $600.00M.
- 2023-12-31: Deferred Tax Liabilities Recognised As Of Acquisition Date $474.00M.
- 2022-12-31: Deferred Tax Liabilities Recognised As Of Acquisition Date $300.00M.
| Period end | Deferred Tax Liabilities Recognised As Of Acquisition Date |
|---|---|
| 2024-12-31 | $799.00M 20-F · filed 2026-02-04 |
| 2024-06-30 | $600.00M 6-K · filed 2024-07-18 |
| 2023-12-31 | $474.00M 20-F · filed 2025-01-31 |
| 2022-12-31 | $300.00M 20-F · filed 2024-01-31 |
| 2022-06-30 | $303.00M 6-K · filed 2023-07-18 |
| 2021-12-31 | $74.00M 20-F · filed 2024-01-31 |
| 2021-06-30 | $31.00M 6-K · filed 2022-07-19 |
| 2020-12-31 | $1.98B 20-F/A · filed 2023-05-15 |
| 2020-06-30 | $1.93B 6-K · filed 2021-07-21 |
| 2019-12-31 | $107.00M 20-F · filed 2022-02-02 |
| 2019-06-30 | $101.00M 6-K · filed 2020-07-21 |
| 2018-12-31 | $2.87B 20-F · filed 2021-01-26 |
| 2017-12-31 | $325.00M 20-F · filed 2020-01-29 |
| 2016-12-31 | $372.00M 20-F · filed 2019-01-30 |